ClinicalTrials.Veeva

Menu

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

B

Banner Health

Status

Withdrawn

Conditions

Substance Withdrawal Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00792415
BHRI#05-08-0074

Details and patient eligibility

About

The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.

Full description

None available.

Sex

All

Ages

2 weeks to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pediatric Intensive Care Unit patients ages 2 weeks to 18 years
  • Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more

Exclusion criteria

  • Attending discretion
  • Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation

Trial design

0 participants in 2 patient groups

1
Description:
Limited continuous opioid exposure (at least 120 and less than 156 hours)
2
Description:
Extended continuous opioid exposure (156 hours or more)

Trial contacts and locations

1

Loading...

Central trial contact

Teri Reyburn-Orne, RN, MSN, PNP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems